ask="1.03"
ask_size="300"
average_daily_volume="1317040"
bid="1.01"
bid_size="1100"
book_value="0.61"
change="-0.04"
change_from_200_day_moving_average="-1.40"
change_from_50_day_moving_average="0.04"
change_from_52_week_high="-3.93"
change_From_52_week_low="0.50"
change_in_percent="-3.85%"
close="1.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.24"
ebitda="-8.78M"
eps_estimate_current_year="-1.12"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="0.19"
ex_dividend_date="N/A"
float_shares="7029000"
high="1.19"
high_52_weeks="4.93"
last_trade_date="2/6/2017"
last_trade_price="1.00"
last_trade_size="4200"
last_trade_time="4:00pm"
low="1.00"
low_52_weeks="0.50"
market_capitalization="7.14M"
moving_average_200_day="2.40"
moving_average_50_day="0.96"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.33"
open="1.08"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-58.41%"
percent_change_from_50_day_moving_average="+4.23%"
percent_change_from_52_week_high="-79.72%"
percent_change_from_52_week_low="+100.00%"
previous_close="1.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="5.26"
price_per_book="1.72"
price_per_sales="2.91"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="0.74"
stock_exchange="NCM"
symbol="OPXA"
volume="1844833"
weeks_range_52="0.50 - 4.93"
